Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

HHS Human Subject Protection Team Will Include Former FDAer Nightingale

Executive Summary

Former FDA Associate Commissioner for Health Affairs Stuart Nightingale, MD, will work on human subject protection issues as one of his responsibilities in a new position at HHS.

You may also be interested in...



Rx "MedGuide" Evaluations Need Consumer Input, Pharmacy Groups Tell FDA

Consumers need to be involved in the assessment of "MedGuide" prescription drug information distributed at pharmacies, several healthcare trade associations said in comments to FDA.

HHS Will Consult With USTR On Patent Relief Claims From Foreign Countries

HHS will have a formal consulting role in future decisions by the U.S. Trade Representative about claims from foreign governments that patent laws hinder their ability to address a public health emergency.

FDA Office of Health Affairs

Office Director Peter Rheinstein will serve as senior VP-medical and clinical affairs at Baltimore, Md.-based Cell Works, after retiring from FDA Sept. 30. The health affairs office was dissolved and partially folded into CDER in June (1"The Pink Sheet" June 28, p. 23)

UsernamePublicRestriction

Register

LL009864

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel